Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
Үндсэн зохиолчид: | Xue, L, Hardman, C, Chen, W, Batty, P, Ogg, G, Erpenbeck, V, Sandham, D |
---|---|
Формат: | Conference item |
Хэвлэсэн: |
American Thoracic Society
2018
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
-н: Chen, W, зэрэг
Хэвлэсэн: (2018) -
Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
-н: Sandham, D, зэрэг
Хэвлэсэн: (2019) -
Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
-н: Hardman, C, зэрэг
Хэвлэсэн: (2019) -
Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)
-н: Xue, L, зэрэг
Хэвлэсэн: (2019) -
Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
-н: Veit J. Erpenbeck, зэрэг
Хэвлэсэн: (2016-12-01)